CBIO / Crescent Biopharma, Inc. - Net Long/Short Value

Crescent Biopharma, Inc.
US ˙ NasdaqCM ˙ US14888D2080

CBIO / Crescent Biopharma, Inc. - Net Long/Short Value
Denne side viser netto-lange/korte værdiansættelser for hver institutionel besiddelse, der er rapporteret via 13F- eller NPORT-ansøgninger. For at beregne netto lang/kort værdi tilføjer vi egenkapitalværdien til værdien af call-optionen og trækker put-optionsværdien fra. Fonde, der rapporterer korte lånte positioner, vil rapportere aktieværdier som negative. Lange nettopositioner vil have positive tal i kolonnen netto lange/korte, og korte nettopositioner vil have negative værdier i denne kolonne.
Ejer Egenkapitalværdi
($1000)
Opkaldsværdi
($1000)
Sæt værdi
($1000)
Netto Lang/Kort
($1000)
Deep Track Capital, LP
Fairmount Funds Management LLC
Frazier Life Sciences Management, L.P.
Tang Capital Management Llc
Morgan Stanley
Boxer Capital Management, LLC
BlackRock, Inc.
Perceptive Advisors Llc
Logos Global Management LP
Jefferies Financial Group Inc.
Blackstone Group Inc
Group One Trading, L.p.
Driehaus Capital Management Llc
Bank Of America Corp /de/
SBI Securities Co., Ltd.
Paradigm Biocapital Advisors LP
VR Adviser, LLC
UBS Group AG
Bvf Inc/il
Adage Capital Partners Gp, L.l.c.
Wellington Management Group Llp
Soleus Capital Management, L.P.
Royal Bank Of Canada
Commodore Capital Lp
Affinity Asset Advisors, LLC
Fmr Llc
Raymond James Financial Inc
Braidwell Lp
Barclays Plc
Bnp Paribas Arbitrage, Sa
Other Listings
DE:C68
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista